Form 4: GE HealthCare CPO Receives Significant Equity Awards
Insider Transaction Report
GE HealthCare's Chief People Officer, Adam Y. Holton, was granted 5,457 restricted stock units and 14,348 employee stock options.
Summary
- Adam Y. Holton, Chief People Officer of GE HealthCare Technologies Inc. (GEHC), was granted equity awards on March 2, 2026.
- The awards include 5,457 restricted stock units (RSUs) of GE HealthCare common stock.
- These RSUs will vest in three tranches: 33% on September 2, 2027, 33% on September 2, 2028, and 34% on September 2, 2029.
- Additionally, Mr. Holton received 14,348 employee stock options with an exercise price of $80.16 per share.
- The stock options will become exercisable on the same schedule as the RSUs: 33% on September 2, 2027, 33% on September 2, 2028, and 34% on September 2, 2029, and expire on March 2, 2036.
- Following these transactions, Mr. Holton beneficially owns 22,225 shares of common stock directly and 14,348 derivative securities (stock options) directly.
Sentiment
Score: 7
Explanation: StockSavvy.ai views this as a moderately positive development, reflecting standard executive compensation practices designed to align management incentives with long-term company performance and shareholder value.
Positives
- The grant of restricted stock units and stock options aligns the Chief People Officer's interests with long-term shareholder value.
- These awards serve as a significant incentive for executive retention and performance over the multi-year vesting period.
Future Outlook
The equity awards are structured with multi-year vesting schedules, indicating a long-term incentive for the Chief People Officer, aligning future performance with the company's strategic goals through September 2029.
Management Comments
- The awards reflect the company's compensation strategy to incentivize key executives through long-term equity participation.
Industry Context
StockSavvy.ai notes that granting restricted stock units and stock options is a standard practice in executive compensation across the healthcare technology industry. This approach aims to retain top talent and align executive performance with shareholder interests over several years, a common strategy for large, established companies like GE HealthCare.
Comparison to Industry Standards
- Executive compensation packages in the healthcare technology sector frequently include a significant equity component, often comprising a mix of restricted stock units and stock options, similar to this award.
- Companies such as Siemens Healthineers AG and Philips NV also utilize multi-year vesting schedules for their executive equity awards to promote long-term commitment and performance.
Management Changes
| Role | Previous Person | New Person | Effective Date | Reason |
|---|---|---|---|---|
| Chief People Officer | N/A | Adam Y. Holton | N/A | N/A (Reporting person's existing role) |
Corporate Governance
| Change Type | Description | Effective Date | Impact Assessment |
|---|---|---|---|
| Executive Compensation Policy | The equity awards are consistent with the company's established executive compensation framework, which includes long-term incentive plans. | 03/02/2026 | Reinforces the company's strategy to use equity-based compensation to attract, retain, and motivate key executives, aligning their interests with shareholder returns. |
Stakeholder Impact
- Shareholders: The awards aim to align the Chief People Officer's long-term interests with shareholder value creation.
- Employees: May signal the company's commitment to competitive executive compensation, potentially influencing broader compensation strategies.
Next Steps
- The restricted stock units will vest in tranches on September 2, 2027, September 2, 2028, and September 2, 2029.
- The employee stock options will become exercisable in tranches on September 2, 2027, September 2, 2028, and September 2, 2029.
Key Dates
| Date | Description |
|---|---|
| 03/02/2026 | Date of equity award transaction for restricted stock units and employee stock options. |
| 03/04/2026 | Date the Form 4 was filed. |
| 09/02/2027 | First vesting date for 33% of restricted stock units and exercisability date for 33% of employee stock options. |
| 09/02/2028 | Second vesting date for 33% of restricted stock units and exercisability date for 33% of employee stock options. |
| 09/02/2029 | Third vesting date for 34% of restricted stock units and exercisability date for 34% of employee stock options. |
| 03/02/2036 | Expiration date for the employee stock options. |
Keywords
GE HealthCare, GEHC, Adam Y. Holton, Chief People Officer, Restricted Stock Units, RSUs, Employee Stock Options, Stock Options, Equity Award, Insider Transaction, Form 4, Executive Compensation
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.